GVHD, ACUTE
Clinical trials for GVHD, ACUTE explained in plain language.
Never miss a new study
Get alerted when new GVHD, ACUTE trials appear
Sign up with your email to follow new studies for GVHD, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug timing strategy aims to shield patients from dangerous transplant complication
Disease control Recruiting nowThis study is testing whether changing when a key drug is given can better prevent a serious complication called graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. It will enroll about 29 adults with leukemia or related disorders who are receiving a …
Matched conditions: GVHD, ACUTE
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for stem cell transplant patients battling serious complication
Disease control Recruiting nowThis study is testing if adding a drug called ruxolitinib to the standard steroid treatment works better for controlling a serious immune reaction called acute GVHD. It is for adults who have had a stem cell transplant for blood cancer and develop this complication. The goal is t…
Matched conditions: GVHD, ACUTE
Phase: PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Feb 23, 2026 14:50 UTC